Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis

Abstract

Rheumatoid arthritis (RA) is characterized by synovial inflammation mediated by T-cells, monocytes and macrophages. The homing of these cells to the inflamed synovium is regulated by chemokine-receptors and their ligands. A 32-basepair deletion (Δ32) in the gene encoding CCR5, a chemokine-receptor, results in a non-functional receptor. A negative association between CCR5-Δ32 and RA has been described, although other studies found no associations. Furthermore, the observation that individuals homozygous for CCR5-Δ32 develop RA has raised questions about the role of CCR5-Δ32. This meta-analysis of all published case–control association studies confirms the negative association between CCR5-Δ32 and RA (Odds Ratio=0.65; 95% confidence intervals=0.55–0.77; P<0.0001), suggesting that CCR5-Δ32 is protective against the development of RA. CCR5 blockade in animal models of RA results in amelioration of arthritis, suggesting that CCR5 blockade could also modify disease in patients with RA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Jawaheer D, Gregersen PK . The search for rheumatoid arthritis susceptibility genes: a call for global collaboration. Arthritis Rheum 2002; 46: 582–584.

    Article  PubMed  Google Scholar 

  2. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN . Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177–182.

    Article  CAS  PubMed  Google Scholar 

  3. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344–345.

    Article  CAS  PubMed  Google Scholar 

  4. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746–754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K . Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999; 11: 553–559.

    Article  CAS  PubMed  Google Scholar 

  6. Ruth JH, Rottman JB, Katschke Jr KJ, Qin S, Wu L, LaRosa G et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001; 44: 2750–2760.

    Article  CAS  PubMed  Google Scholar 

  7. Katschke Jr KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1022–1032.

    Article  CAS  PubMed  Google Scholar 

  8. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN . Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995; 101: 398–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93: 921–928.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367–377.

    Article  CAS  PubMed  Google Scholar 

  11. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–725.

    Article  CAS  PubMed  Google Scholar 

  12. Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben Sorensen S et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 1998; 25: 1462–1465.

    CAS  PubMed  Google Scholar 

  13. Gomez-Reino JJ, Pablos JL, Carreira PE, Santiago B, Serrano L, Vicario JL et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum 1999; 42: 989–992.

    Article  CAS  PubMed  Google Scholar 

  14. Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 487–490.

    Article  CAS  PubMed  Google Scholar 

  15. Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V . CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000; 1: 288–289.

    Article  CAS  PubMed  Google Scholar 

  16. Cooke SP, Forrest G, Venables PJ, Hajeer A . The delta32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1135–1136.

    Article  CAS  PubMed  Google Scholar 

  17. John S, Smith S, Morrison JF, Symmons D, Worthington J, Silman A et al. Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis. Arthritis Rheum 2003; 48: 3615–3616.

    Article  PubMed  Google Scholar 

  18. Venables PJ, Hajeer A . Delta32CCR5 and rheumatoid arthritis: comment on the article by Gomez-Reino et al. Arthritis Rheum 1999; 42: 2732–2733.

    Article  CAS  PubMed  Google Scholar 

  19. Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999; 42: 981–988.

    Article  CAS  PubMed  Google Scholar 

  20. Zuniga JA, Villarreal-Garza C, Flores E, Barquera R, Perez-Hernandez N, Montes de Oca JV et al. Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol 2003; 21: 351–354.

    CAS  PubMed  Google Scholar 

  21. Bakhiet M, Tjernlund A, Mousa A, Gad A, Stromblad S, Kuziel WA et al. RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol 2001; 3: 150–157.

    Article  CAS  PubMed  Google Scholar 

  22. Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 1999; 96: 12004–12009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Bamshad MJ, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, Watkins WS et al. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc Natl Acad Sci USA 2002; 99: 10539–10544.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000; 275: 18946–18961.

    Article  CAS  PubMed  Google Scholar 

  25. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156: 300–310.

    Article  PubMed  Google Scholar 

  26. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR . Publication bias in clinical research. Lancet 1991; 337: 867–872.

    Article  CAS  PubMed  Google Scholar 

  27. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN . Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997; 57: 117–120.

    Article  CAS  PubMed  Google Scholar 

  28. Yang YF, Mukai T, Gao P, Yamaguchi N, Ono S, Iwaki H et al. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur J Immunol 2002; 32: 2124–2132.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from The National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR50177), The National Center for Research Resources (M01-RR00064), The Val A Browning Charitable Foundation, and the Children's Health Research Center, Salt Lake City, UT. We would like to acknowledge Lynn Jorde PhD, Department of Human Genetics for critical review of the manuscript and suggestions for analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Prahalad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prahalad, S. Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 7, 264–268 (2006). https://doi.org/10.1038/sj.gene.6364298

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364298

Keywords

This article is cited by

Search

Quick links